Drug Database
Back to search

Ireland· IE-PA-PA2315/265/001

Pazopanib Accord 200 mg film-coated tablets

A antineoplastic agents product containing pazopanib hydrochloride, registered in Ireland by Accord Healthcare Ireland Ltd.. The same ATC class is registered in 6 of our 19 countries.

ATC L01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedPazopanib Accord 200 mg film-coated t…ATCL01REGISTER NO.IE-PA-PA2315/265/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pazopanib hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pazopanib hydrochloride is registered in 6 of 19 countries.

Countries holding a registration under ATC L01 (antineoplastic agents), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 3 of them publish a price we can compare per daily dose
Search pazopanib hydrochloride products by name

Pazopanib hydrochloride · ATC L01

6 / 19 countries

  • Canada
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Pazopanib hydrochloride
Manufacturer
Accord Healthcare Ireland Ltd.
Country
Ireland (IE)
ATC code
L01
ATC class
ANTINEOPLASTIC AGENTS
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA2315/265/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Pazopanib hydrochloride in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pazopanib hydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Pazopanib Devatis
  • Belgium · Pazopanib Accord, Pazopanib Eg
  • Bulgaria · Алуниб, Пазопаниб G.L. Pharma
  • Cyprus · Pazopanib Sapiens, Pazorem
  • Czechia · Pazopanib Accord, Pazopanib Sandoz
  • Germany · Pazopanib Al, Pazopanib Beta
  • Denmark · Pazopanib Accord, Pazopanib Glenmark
  • Estonia · Pazopanib Accord, Pazopanib Teva
  • Spain · Pazopanib Accord, Pazopanib Dr. Reddys
  • Finland · Pazopanib Accord, Pazopanib Glenmark
  • France · Pazopanib Accord, Pazopanib Biogaran
  • United Kingdom (Northern Ireland) · Pazopanib Accord, Pazopanib Accord Healthcare
  • Greece · Pazopanib Accord, Pazopanib Stada
  • Croatia · Pazopanib Accord, Pazopanib Frontier
  • Hungary · Pazopanib Accord, Pazopanib G.L. Pharma
  • Iceland · Pazopanib Adalvo, Pazopanib Stada
  • Italy · Pazopanib Accord, Pazopanib Dr. Reddy’s
  • Liechtenstein · Votrient
  • Lithuania · Pazopanib Accord, Pazopanib Auxilia
  • Luxembourg · Pazopanib Eg, Pazopanib Pazopanib Eg
  • Latvia · Pazopanib Accord, Pazopanib Teva
  • Malta · Pazopanib Pharmacare, Pazopanib Pharos
  • Netherlands · Pazopanib Accord, Pazopanib Cf
  • Norway · Pazopanib Accord, Pazopanib Glenmark
  • Poland · Pazopanib Accord, Pazopanib Glenmark
  • Portugal · Pazopanib Accord, Pazopanib Bluepharma
  • Romania · Pazopanib Accord, Pazopanib Dr. Reddys
  • Sweden · Pazopanib Accord, Pazopanib Glenmark
  • Slovenia · Pazopanib Accord, Pazopanib Teva
  • Slovakia · Pazopanib Accord, Pazopanib G.L. Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b50c2c73-5ea0-4e7a-9b7c-82ba3ee03c75
GET /v1/drugs/b50c2c73-5ea0-4e7a-9b7c-82ba3ee03c75?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01"
  ],
  "strength": null,
  "pa_number": "PA2315/265/001",
  "substances": [
    "Pazopanib hydrochloride"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "08/12/2023",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0194-067-003"
}
API referenceMCP serverPlans

See everything about pazopanib hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console